A Phase I Study of GFH312 in Healthy Chinese Subjects

NCT05991362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: GFH312 100 mg
DRUG: GFH312 200 mg
DRUG: GFH312 120mg
OTHER: Placebo

Sponsor

Zhejiang Genfleet Therapeutics Co., Ltd.